Press Release
Category Added in a WPeMatico Campaign
-
Skymizerʼs HyperThought™ Wins “Best IP/Processor of the Yearˮ and “Most Promising Productˮ at EE Awards Asia 2025
TAIPEI, Dec. 6, 2025 /PRNewswire/ — Skymizer today announced that its next-generation HyperThought™ LLM Accelerator IP has been awarded “Best…
Read More » -
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China’s National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops,…
Read More » -
MarketersMEDIA Newswire2 weeks agoFinaive Announces AI-Powered Fraud Prevention System for Digital Commerce
Finaive unveils an innovative AI-driven marketplace and fraud prevention system, providing enhanced security for online transactions with predictive AI intelligence.…
Read More » -
MarketersMEDIA Newswire2 weeks agoGenerative AI Meets Personal Branding: Jerry Hsu’s Disruptive Model for 2025 and Beyond
Jerry Hsu introduces AI-driven personal branding coaching to enhance business growth and personal influence in 2025 and beyond. Taiwan, December…
Read More » -
SK hynix Honored with Two Major Titles at GSA Awards 2025
Company named “Best Financially Managed Semiconductor Company (Achieving Greater than $1 Billion in Annual Sales)” and “Outstanding Asia-Pacific Semiconductor Company”…
Read More » -
Business Wire2 weeks ago
Memphis Shines as Thousands Unite for St. Jude Memphis Marathon Weekend
MEMPHIS, Tenn.–(BUSINESS WIRE)–The spirit of Memphis was on full display this weekend as tens of thousands of runners, patient families,…
Read More » -
Business Wire2 weeks ago
Rosen Law Firm Encourages Klarna Group plc Investors to Inquire About Securities Class Action Investigation – KLAR
NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on…
Read More » -
Business Wire2 weeks ago
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
Findings from the Phase 3 study were presented at the 67th American Society of Hematology Annual Meeting and Exposition and…
Read More » -
MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. BOSTON, Dec.…
Read More » -
Business Wire2 weeks ago
Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting
VGA039 is a once monthly, subcutaneously self-administered therapy for the treatment of bleeding disorders, starting with von Willebrand disease (VWD)…
Read More »